Back
icad 10K Form
Sell
42
ICAD
icad
Last Price:
$3.87
Seasonality Move:
0.58%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-15 | 10Q | ICAD/icad Quarterly |
| 2023-11-14 | 10Q | ICAD/icad Quarterly |
| 2023-08-11 | 10Q | ICAD/icad Quarterly |
| 2023-05-15 | 10Q | ICAD/icad Quarterly |
| 2022-11-14 | 10Q | ICAD/icad Quarterly |
| 2022-08-15 | 10Q | ICAD/icad Quarterly |
Receive ICAD News And Ratings
See the #1 stock for the next 7 days that we like better than ICAD
ICAD Financial Statistics
Sales & Book Value
| Annual Sales: | $19.6M |
|---|---|
| Cash Flow: | $-197K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.13 |
| Price / Book: | 3.44 |
Profitability
| EPS (TTM): | -0.20000 |
|---|---|
| Net Income (TTM): | $-5.2M |
| Gross Margin: | $16.6M |
| Return on Equity: | -17.16% |
| Return on Assets: | -13.51% |
icad Earnings Forecast
Key icad Financial Ratios
-
The Gross Profit Margin over the past 38 years for ICAD is 84.84%.
-
The Selling, General & Administrative Expenses for ICAD have been equal to 81.86% of Gross Profit Margin.
-
The Research & Development expenses have been 33.71% of Revenue.
-
The Net Earning history of ICAD is -28.64% of Total Revenues.
-
Per Share Earnings over the last 38 years have been positive in 20 years.
icad Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | ICAD |
| CUSIP: | 44934S |
| Website: | icadmed.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.66 |
| Quick Ratio: | 3.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |